ENDRA Life Sciences Inc. — Income Charts
5 years of history · ending 2020-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-100.0% -$516K
$0
Cost of Revenue
$0
Gross Profit↓-100.0% -$280K
$0
R&D↑+1094.6% +$5M
$6M
D&A↑+53.0% +$34K
$99K
Operating Income↓-541.9% -$10M
$-12M
EBITDA↓-560.3% -$10M
$-11M
Interest Expense
$0
Other Income/Expense↑+75.5% +$688K
$-224K
Pretax Income↓-322.5% -$9M
$-12M
Tax Provision
$0
Net Income↓-322.5% -$9M
$-12M
Gross Margin
100.0%
Operating Margin
-146080.5%
Net Margin
-158669.6%
Effective Tax Rate↑+0.0pts
0.0%
Deferred Tax Assets
$0
DTA Valuation Allowance↑+196.8% +$7M
$11M
Tax Credit Carryforwards
—
NOL Carryforwards↑+202.6% +$7M
$11M
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↓-13.0pts
21.0%
ETR State + Local (pp)↑+5.8pts
0.0%
ETR Foreign Differential (pp)
0.0%
Operating Lease Cost↑+116.0% +$65K
$120K
Revenue YoY Variation
-100.0%
Income YoY Variation
-6.1%